غالكسوسميثكلاين العالمية للمواد الصيدلانية والأدوية

worldwide, press, world, select, research, glaxosmithkline, december, united, search, releases, paroxetine, media, london, jump, infanrix, antibiotic, zovirax, zantac, updated, tagamet, super, students, strategy, site, rythmol, republic, report, release, registered, products, price, powder, poligrip, polident, patients, odol, medicine, lymphatic, kingdom, investors, information, home, graduates, flixonase, filariasis, fighting, eumovate, eliminate, development, deadlock, corporate, coreg, commitment, collaboration, clinical, careers, break, beconase, zyban, zofran, zinnat, zinacef, zeffix, zealand, years, working, work, west, wernets, wellvone, wellbutrin, welcomes, website, wales, votrient, volibris, viva, vietnam, veramyst, ventolin, venezuela, varilrix, valtrex, valda, vaccines, vaccine, uzbekistan, uruguay, update, ultra, ultiva, ukraine, tyverb, typherix, tykerb, twinrix, turkey, tums, trobalt, trinidad, trimovate, treximet, tracrium, tool, timentin, thursday, thailand, terms, targon, taiwan, tackle, tabloid, synthol, synflorix, switzerland, sweden, subscribe, submits, study, stock, staxyn, states, statement, stanback, speech, spain, south, sominex, solpadeine, social, slovenia, slovakia, singapore, shumitect, shareholders, share, services, seroxat, serevent, seretide, serbia, sensodyne, scotts, sciences, saudi, salvador, rutinoscorbin, russia, rupafin, rotarix, romania, road, rights, right, rica, ribena, revolade, results, respontin, responsibility, response, resistance, residents, reserved, requip, reports, reporting, relenza, regulatory, register, read, quitters, publications, public, provider, provided, promacta, programme, product, procurement, privacy, priorix, prime, prescription, pregnancy, portugal, poland, piriton, pipeline, philippines, phazyme, peru, pentostam, pediatric, pediarix, paxil, past, partnership, partners, parodontax, parnate, pandemrix, panama, panadol, panadeine, pakistan, page, oxide, otosporin, organisation, official, office, nytol, nyse4391, norway, niquitin, nimbex, nigeria, nicorette, nicoderm, nicaragua, nicabate, news, netherlands, navigation, naramig, myanmar, morocco, moldova, mivacron, mission, minutes, minute, ministers, middlesex, mexico, mepron, menitorix, meningococcal, mejoral, medicines, medacalm, med3, maxinutrition, massengill, maltova, malta, malaysia, malarone, macleans, macedonia, lucozade, lse1400p, lozenge, lovaza, longer, live, lithuania, liskonum, limited, life, libenar, levitra, latvia, lanoxin, lanka, lamictal, lactacyd, laboratory, korea, kong, kinrix, kenya, kazakhstan, journalists, japan, jamaica, jalyn, italy, israel, ireland, ipvhib, iodosan, iodex, involving, investis, intended, integrilin, insto, innopran, industry, indonesia, india, imitrex, imigran, iceland, hycamtin, hungary, horlicks, horizant, hong, honduras, hinds, hibitane, hiberix, herzegovina, hepatyrix, help, health, havrix, guatemala, greece, great, granufink, goodys, germany, georgia, gaviscon, fund, france, fortum, fortaz, formigran, formed, footer, flulaval, fluarix, flovent, flonase, flolan, flixotide, finland, fiberchoice, fendrix, fenbid, feel, feeds, feed, exchange, european, estonia, entereg, england, engerix, emulsion, employees, egypt, effect, ecuador, ecotrin, earnings, dynacirc, dyazide, donation, dominican, digibind, developing, detailed, dermovate, dequadin, denmark, debrox, data, daraprim, czech, cyprus, cutivate, crocin, croatia, country, costa, cortal, corsodyl, corega, core, content, contacts, contact, contac, consumer, conditions, communities, committed, commits, commit, commissions, combodart, combination, colombia, collaborative, collaborations, coldrex, citrucel, cholinex, chlorhexamed, china, chile, charting, chap, cetebe, cervarix, centre, ceftin, candidate, canada, cambodia, business, bulgaria, brentford, breathe, brazil, brands, bosnia, boostrix, boniva, blog, biotene, binaca, bexxar, better, betnovate, best, benlysta, belgium, belarus, begin, beechams, becodisks, beano, basis, bangladesh, bactroban, azerbaijan, avodart, avandia, avandaryl, avandamet, avamys, austria, australia, augmentin, atriance, astriginsol, arzerra, arranon, armenia, arixtra, argentina, argatroban, archive, arabia, aquafresh, antiparasitic, annual, anectine, analystsinvestors, amoxil, amerge, ambirix, altargo, altabax, alli, allergy, algeria, albendazole, albania, africa, advanced, advair, adult, adolescent, additional, adartrel, acwy, accessibility, access, abtei, abreva, http://www.gsk.com/common/img/media/olympics/2012-logo-dual.png, http://www.gsk.com//common/img/logo-gsk.gif, Your privacy, Worldwide map, Working at GSK, What are RSS feeds?, US media and news, US job search, US corporate website, UK job search, The World of GSK, The World of GSK, Terms and conditions, Subscribe to press release RSS feed, Students & graduates US, Students & graduates UK, Social media, Site map, Site map, Responsibility, Research & development, Reports and publications, Reporting on a core earnings basis will begin with effect from Q1 2012, Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine, Read about the collaboration to break deadlock in antibiotic research, Product pipeline, Procurement, Paroxetine and pregnancy, Paroxetine and pediatric and adolescent patients, Paroxetine and adult patients, Our work with communities, Our products, Our mission and strategy, Our commitment to the developing world, Official Laboratory Services Provider to London 2012, More Than Medicine blog, More about our commitment to eliminate lymphatic filariasis, Media centre, Jump to navigation, Jump to footer, Jump to content, IW access for GSK employees, Investors, Information for shareholders, Home, GSK worldwide map, GSK worldwide contacts, GSK worldwide, GSK statement in response to the Prime Ministers speech on life sciences, GSK press releases from the past four years, Fighting LF, Detailed share price and charting tool, Contact us, Collaborations, Clinical Study Register, Careers home page, Careers, Annual Report 2010, Advanced search, Accessibility, About us, 26 Oct: Q3 2011 results, 2010 CR Report, GlaxoSmithKline, Products, GSK worldwide, GSK and London 2012, Fighting lymphatic filariasis, Do more, feel better, live longer, Corporate press releases, Collaboration to break deadlock in antibiotic research, Vaccines, Press release archive, Prescription medicines, For US residents, Consumer brands, Clinical data,